Pancreatic Cancer Research

ResearcherAffiliated Hospital of Guizhou Medical UniversityActive in the last 2 years

Lei Feng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6053-8417; OpenAlex author ID A5023910969, A5137820934. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 4

  1. Integrated single-cell and bulk RNA sequencing reveals regulated necrosis-associated heterogeneity in pancreatic cancer. Co-author DOI 10.1007/s12094-026-04437-y↗
  2. Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic cancer. Co-author DOI 10.1111/jgh.16401↗
  3. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer. Co-author DOI 10.1155/2021/6673125↗
  4. Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.738709↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhonghui Zhu · 1 shared paper, 2026 · strength 0.50
  2. Chenjie Zhou · 3 shared papers, 2021–2024 · strength 0.47
  3. Yi Gao · 2 shared papers, 2021–2024 · strength 0.35
  4. Shulong Li · 1 shared paper, 2024 · strength 0.22
  5. Adilijiang Yimamu · 1 shared paper, 2024 · strength 0.22
  6. Yi Gao · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.